KERALA AYURVEDA
Back to Cashflow Statement
|
KERALA AYURVEDA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-9.48 Cr | ₹18 Cr | ₹-1.14 Cr | ₹-13 Cr | ₹6.20 Cr |
What is the latest Cash Flow from Financing Activities ratio of KERALA AYURVEDA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-9.48 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹-1.14 Cr |
| Mar2022 | ₹-13 Cr |
| Mar2021 | ₹6.20 Cr |
How is Cash Flow from Financing Activities of KERALA AYURVEDA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-9.48 Cr | Negative | |
| Mar2024 | ₹18 Cr | Positive | |
| Mar2023 | ₹-1.14 Cr | Negative | |
| Mar2022 | ₹-13 Cr | Negative | |
| Mar2021 | ₹6.20 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹224.7 Cr | -1.9% | 1% | -64.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,223.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹183,453.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹109,849.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,591.8 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -1.9% |
1% |
-64.6% |
| SENSEX | -1.6% |
-4.7% |
-8.3% |
You may also like the below Video Courses